Pediatric Infectious Disease Fellowship
All fellows choose a Scholarly Activity resulting in a work product in accordance with American Board of Pediatrics requirements. The program provides access to a wide variety of opportunities for this major project. Additionally, most fellows also complete smaller research projects for publication, such as descriptive case series, retrospective case control studies, or prospective interventional studies, and present study findings at national meetings.
Fellows in this track usually will complete a scholarly activity in clinical research, either in general infectious diseases or HIV-related care. Opportunities for research related to global health and epidemiology/infection control also are possible. Research mentors generally are based at CNMC or its research arm, Children's Research Institute. Research mentors from other institutions, such as NIH or George Washington University, also are available for collaboration.
In the FDA Tracks, the Scholarly Activity is based on the fellow's major review endeavors at the FDA, either related to antimicrobial agents (CDER fellow) or vaccines (CBER fellow). For both CDER and CBER fellows, approximately two-thirds of the fellowship is spent at the FDA, with primary focus of reviewing a new product for possible FDA approval. These work products represent a comprehensive study of a new product, with a report considerably longer and more detailed than a journal article.
Fellows review animal data, pharmacology, clinical trial protocols, and other data under the mentorship of CDER physicians, biostatisticians, and other personnel, for new antimicrobial agents submitted for approval. CDER fellows work in the Division of Anti-Infective Products and in the Division of Antiviral Products, housed within FDA's Office of Antimicrobial Products.
Similar to CDER fellows, CBER fellows review scientific data for consideration of licensing of new vaccines. They work in the Office of Vaccines Research and Review at CBER.